SCHEMBL7086273

SCHEMBL7086273

O=C(O)C1=CC=C2NCCC2C1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.37
MAPK1 P28482 1/20 0.37
HSD17B10 Q99714 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
BLM P54132 3/20 0.36
THRB P10828 1/20 0.36
PMP22 Q01453 1/20 0.36
KMT2A Q03164 1/20 0.36
GABRR1 P24046 2/20 0.32
SLC6A1 P30531 1/20 0.32
SLC6A13 Q9NSD5 1/20 0.32
GABRP O00591 1/20 0.32
GABRD O14764 1/20 0.32
GABRA1 P14867 1/20 0.32
GABRB1 P18505 1/20 0.32
GABRG2 P18507 1/20 0.32
GABRB3 P28472 1/20 0.32
GABRA5 P31644 1/20 0.32
GABRA3 P34903 1/20 0.32
GABRA2 P47869 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7085716 0.71 TSHR (0.37) TSHRMAPK1HSD17B10TDP1BLM
SCHEMBL1004482 0.67 KDM4E (0.31)
Hydrochloric Acid SCHEMBL10445256 0.67 BLM (0.39) TSHRMAPK1HSD17B10TDP1BLM
SCHEMBL6981423 0.64 TSHR (0.37) TSHRMAPK1HSD17B10TDP1BLM
SCHEMBL5239395 0.64 TSHR (0.37) TSHRMAPK1HSD17B10TDP1BLM
SCHEMBL7672763 0.64 TSHR (0.37) TSHRMAPK1HSD17B10TDP1BLM
SCHEMBL5964209 0.63
SCHEMBL7086432 0.63 GABRP (0.31) TSHRBLMGABRR1GABRPGABRD
Hydrochloric Acid SCHEMBL18320900 0.62 LMNA (0.33) TSHRBLMGABRR1GABRPGABRD
SCHEMBL31564553 0.59 TSHR (0.35) TSHRMAPK1HSD17B10TDP1BLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109475530-A For treating the aminoacyl indazole immunomodulator of autoimmune disease 洛克菲勒大学 2019-03-15 CN disclosed
EP-1326831-A1 SUBSTITUTED FUSED PYRROLEIMINES AND PYRAZOLEIMINES NEUROGEN CORPORATION (US) 2003-07-16 EP disclosed
WO-2002020480-A1 SUBSTITUTED FUSED PYRROLEIMINES AND PYRAZOLEIMINES NEUROGEN CORPORATION (US) 2002-03-14 WO disclosed